Maravai LifeSciences Holdings, Inc. - Class A
News
Principal Financial Group Inc. Has $4.77 Million Position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Ticker Report Principal Financial Group Inc. raised its stake in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 62.4% in the 2nd quarter, according to its most recent 13F filing with...\n more…
Brokerages Set Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Price Target at $10.78
Ticker Report Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Get Free Report) has been assigned an average rating of "Moderate Buy" from the nine brokerages that are covering the company, Marketbeat Ratings...\n more…
Maravai Lifesciences Holdings (MRVI) Gets a Buy from Wells Fargo
TipRanks Financial Blog In a report released on September 6, Brandon Couillard from Wells Fargo maintained a Buy rating on Maravai Lifesciences Holdings (MRVI - Research R...\n more…
Liontrust Investment Partners LLP Has $314,000 Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Zolmax Liontrust Investment Partners LLP increased its holdings in shares of Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 14.7% in the second quarter, according to the company in its...\n more…
Cygnus Technologies and TriLink BioTechnologies Collaborate to Launch AccuRes Host Cell DNA Quantification Kits
Business Wire Cygnus Technologies (Cygnus), TriLink BioTechnologies (TriLink), both part of Maravai LifeSciences (NASDAQ: MRVI) have collaborated to launch Cygnus AccuRes Host Cell DNA Quantification Kits...\n more…
Wedmont Private Capital Has $276,000 Stock Holdings in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI)
Zolmax Wedmont Private Capital decreased its position in Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI - Free Report) by 9.3% during the 2nd quarter, according to the company in its most recent...\n more…